CRL
$337.52+7.83%
as of close, Nov 6, 2026
☾ AH $337.52 +7.83%
Charles River LaboratoriesStock · HealthcareS&P 500 Equal Weight · 0.2% of RSPS&P 500 · 0.02% of SPYRussell 3000 · 0.02% of IWVRussell 1000 · 0.02% of IWBUS Stock Market · 0.02% of VTI
Head-to-head:Compare with RVTY or any ticker →
Charles River Laboratories total returns by year (including dividends)
As of market close, Nov 6, 2026
Every year since 2000#
Data provided bySource: Twelve DataCalendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start | End | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $199.48 | $337.52 | 0.0% | +69.2% | |
| 2025 | $184.60 | $199.48 | 0.0% | +8.1% | |
| 2024 | $236.40 | $184.60 | 0.0% | -21.9% | |
| 2023 | $217.90 | $236.40 | 0.0% | +8.5% | |
| 2022 | $376.78 | $217.90 | 0.0% | -42.2% | |
| 2021 | $249.86 | $376.78 | 0.0% | +50.8% | |
| 2020 | $152.76 | $249.86 | 0.0% | +63.6% | |
| 2019 | $113.18 | $152.76 | 0.0% | +35.0% | |
| 2018 | $109.45 | $113.18 | 0.0% | +3.4% | |
| 2017 | $76.19 | $109.45 | 0.0% | +43.7% | |
| 2016 | $80.39 | $76.19 | 0.0% | -5.2% | |
| 2015 | $63.64 | $80.39 | 0.0% | +26.3% | |
| 2014 | $53.04 | $63.64 | 0.0% | +20.0% | |
| 2013 | $37.47 | $53.04 | 0.0% | +41.6% | |
| 2012 | $27.33 | $37.47 | 0.0% | +37.1% | |
| 2011 | $35.54 | $27.33 | 0.0% | -23.1% | |
| 2010 | $33.69 | $35.54 | 0.0% | +5.5% | |
| 2009 | $26.20 | $33.69 | 0.0% | +28.6% | |
| 2008 | $65.80 | $26.20 | 0.0% | -60.2% | |
| 2007 | $43.25 | $65.80 | 0.0% | +52.1% | |
| 2006 | $42.37 | $43.25 | 0.0% | +2.1% | |
| 2005 | $46.01 | $42.37 | 0.0% | -7.9% | |
| 2004 | $34.33 | $46.01 | 0.0% | +34.0% | |
| 2003 | $38.48 | $34.33 | 0.0% | -10.8% | |
| 2002 | $33.48 | $38.48 | 0.0% | +14.9% | |
| 2001 | $27.38 | $33.48 | 0.0% | +22.3% | |
| 2000since Jun 23 | $22.00 | $27.38 | 0.0% | +24.4% |
- Annualized
- +10.9%
- 2001–2026
- Average year
- +13.0%
- 25 full years
- Best year
- +63.6%
- 2020
- Worst year
- -60.2%
- 2008
- Positive years
- 18/25
- 72% up
Annualized (CAGR)
+10.9%
2001–2026
Average year
+13.0%
25 full years
Best year
+63.6%
2020
Worst year
-60.2%
2008
Positive years
18/25
72% up
Total return by period#
Annual
-60%-40%-20%0%20%40%60%
2000, since Jun 23+24%'00
2001+22%
2002+15%'02
2003-11%
2004+34%'04
2005-7.9%
2006+2.1%'06
2007+52%
2008-60%'08
2009+29%
2010+5.5%'10
2011-23%
2012+37%'12
2013+42%
2014+20%'14
2015+26%
2016-5.2%'16
2017+44%
2018+3.4%'18
2019+35%
2020+64%'20
2021+51%
2022-42%'22
2023+8.5%
2024-22%'24
2025+8.1%
2026+69%'26
Methodology#
Total returns, dividends reinvested, measured on CRL. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Charles River Laboratories's average annual return?
- Since 2001, Charles River Laboratories (CRL) has returned about 10.9% a year (the compound annual growth rate) and an average calendar-year return of 13.0%.
- What were Charles River Laboratories's best and worst years?
- Over 2001–2026, the best year was 2020 (+63.6%) and the worst was 2008 (-60.2%).
- How often is Charles River Laboratories up in a year?
- 18 of the 25 full years since 2001 were positive — about 72% of the time.
More on Charles River Laboratories
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100
Head-to-head:Compare with RVTY or any ticker →